This is Sinopharm vaccine," BPOM Head Penny Lukito stated during a virtual press conference here on Friday. The agency has conducted evaluation involving the National Committee on COVID-19 Vaccine Assessor and the Indonesian Technical Advisory Group on Immunization (ITAGI) before issuing the EUA. The team reported that the Sinopharm vaccine has an efficacy rate of 78 percent based on the third phase of clinical test conducted in the United Arab Emirates and several other countries involving 42 thousand human subjects.